Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 236

Similar articles for PubMed (Select 23094073)

1.

WNT10A plays an oncogenic role in renal cell carcinoma by activating WNT/β-catenin pathway.

Hsu RJ, Ho JY, Cha TL, Yu DS, Wu CL, Huang WP, Chu P, Chen YH, Chen JT, Yu CP.

PLoS One. 2012;7(10):e47649. doi: 10.1371/journal.pone.0047649. Epub 2012 Oct 19.

2.

Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.

Kojima T, Shimazui T, Hinotsu S, Joraku A, Oikawa T, Kawai K, Horie R, Suzuki H, Nagashima R, Yoshikawa K, Michiue T, Asashima M, Akaza H, Uchida K.

Oncogene. 2009 Jan 15;28(2):297-305. doi: 10.1038/onc.2008.391. Epub 2008 Oct 20.

PMID:
18931698
3.

The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.

Shiina H, Igawa M, Breault J, Ribeiro-Filho L, Pookot D, Urakami S, Terashima M, Deguchi M, Yamanaka M, Shirai M, Kaneuchi M, Kane CJ, Dahiya R.

Clin Cancer Res. 2003 Jun;9(6):2121-32.

4.

Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.

Chen H, Wang Y, Xue F.

Oncol Rep. 2013 Feb;29(2):507-14. doi: 10.3892/or.2012.2126. Epub 2012 Nov 7.

PMID:
23135473
5.

Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma.

Ueno K, Hirata H, Majid S, Chen Y, Zaman MS, Tabatabai ZL, Hinoda Y, Dahiya R.

Mol Carcinog. 2011 Jun;50(6):449-57. doi: 10.1002/mc.20729. Epub 2011 Jan 25.

PMID:
21268126
6.

Redundant expression of canonical Wnt ligands in human breast cancer cell lines.

Benhaj K, Akcali KC, Ozturk M.

Oncol Rep. 2006 Mar;15(3):701-7.

PMID:
16465433
7.

Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.

Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Ueno K, Yamamura S, Zaman MS, Khatri G, Chen Y, Saini S, Majid S, Deng G, Ishii N, Dahiya R.

Int J Cancer. 2011 Apr 15;128(8):1793-803. doi: 10.1002/ijc.25507.

PMID:
20549706
8.

Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways.

Hirata H, Hinoda Y, Nakajima K, Kawamoto K, Kikuno N, Kawakami K, Yamamura S, Ueno K, Majid S, Saini S, Ishii N, Dahiya R.

Clin Cancer Res. 2009 Sep 15;15(18):5678-87. doi: 10.1158/1078-0432.CCR-09-0558.

9.

Protein tyrosine phosphatase ζ enhances proliferation by increasing β-catenin nuclear expression in VHL-inactive human renal cell carcinoma cells.

Shang D, Xu X, Wang D, Li Y, Liu Y.

World J Urol. 2013 Dec;31(6):1547-54. doi: 10.1007/s00345-013-1077-4. Epub 2013 Apr 16.

PMID:
23588815
10.

IGFBP-4 activates the Wnt/beta-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma.

Ueno K, Hirata H, Majid S, Tabatabai ZL, Hinoda Y, Dahiya R.

Int J Cancer. 2011 Nov 15;129(10):2360-9. doi: 10.1002/ijc.25899. Epub 2011 Apr 7.

PMID:
21207373
11.

Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.

Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R.

Clin Cancer Res. 2006 Jan 15;12(2):383-91.

12.

Down-regulation of Wnt10a by RNA interference inhibits proliferation and promotes apoptosis in mouse embryonic palatal mesenchymal cells through Wnt/β-catenin signaling pathway.

Feng C, Xu Z, Li Z, Zhang D, Liu Q, Lu L.

J Physiol Biochem. 2013 Dec;69(4):855-63. doi: 10.1007/s13105-013-0262-7. Epub 2013 May 28.

PMID:
23712503
13.

Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.

Saini S, Liu J, Yamamura S, Majid S, Kawakami K, Hirata H, Dahiya R.

Cancer Res. 2009 Sep 1;69(17):6815-22. doi: 10.1158/0008-5472.CAN-09-1254.

14.
15.

Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.

Yu CP, Ho JY, Huang YT, Cha TL, Sun GH, Yu DS, Chang FW, Chen SP, Hsu RJ.

PLoS One. 2013;8(2):e56667. doi: 10.1371/journal.pone.0056667. Epub 2013 Feb 27.

16.

Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.

Matsubayashi S, Nakashima M, Kumagai K, Egashira M, Naruke Y, Kondo H, Hayashi T, Shindo H.

Pathol Res Pract. 2009;205(9):626-33. doi: 10.1016/j.prp.2009.02.011. Epub 2009 Mar 25.

PMID:
19324500
17.

EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.

Cheng AS, Lau SS, Chen Y, Kondo Y, Li MS, Feng H, Ching AK, Cheung KF, Wong HK, Tong JH, Jin H, Choy KW, Yu J, To KF, Wong N, Huang TH, Sung JJ.

Cancer Res. 2011 Jun 1;71(11):4028-39. doi: 10.1158/0008-5472.CAN-10-3342. Epub 2011 Apr 21.

18.

Wnt signaling pathway analysis in renal cell carcinoma in young patients.

Bruder E, Moch H, Ehrlich D, Leuschner I, Harms D, Argani P, Briner J, Graf N, Selle B, Rufle A, Paulussen M, Koesters R.

Mod Pathol. 2007 Dec;20(12):1217-29. Epub 2007 Sep 14.

19.

beta-catenin expression and mutational analysis in renal cell carcinomas.

Kim YS, Kang YK, Kim JB, Han SA, Kim KI, Paik SR.

Pathol Int. 2000 Sep;50(9):725-30.

PMID:
11012986
20.

The role of Wnt/beta-catenin signaling in renal carcinogenesis: lessons from cadmium toxicity studies.

Thévenod F, Chakraborty PK.

Curr Mol Med. 2010 Jun;10(4):387-404. Review.

PMID:
20455852
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk